Mark Leschly

Mark Leschly

Director/Board Member bij CHARGEPOINT HOLDINGS, INC.

Vermogen: 908 439 $ op 31-03-2024

55 jaar
Health Technology
Finance
Technology Services

Profiel

Mark Leschly is the founder and currently holds the position of Director at MMAX Investment Partners, Inc. which was founded in 2017.
He is also currently the Chairman & Chief Executive Officer at Universal Tennis LLC, Chairman & Chief Executive Officer at Universal Tennis Management LLC, Director at ChaCha Search, Inc., Director at Fabletics, Inc., Director at Tapjoy, Inc., Director at Greenfly, Inc., Managing Director at Iconica LLC, Independent Director at ChargePoint Holdings, Inc. since 2009, Director at Professional Fighters League LLC, Managing Partner at Rho Capital since 1999, Managing Partner at Rho Capital Partners, Inc. since 1999, Managing Partner at Rho Fund Investors since 1999, and Manager Member & Owner at Iconia LLC since 2014.
Mr. Leschly's former positions include Chairman at Senomyx, Inc. from 2001 to 2008, Director at NetMed, Inc., Director at Vicuron Pharmaceuticals LLC, Director at NitroMed, Inc., Director at Tercica, Inc. from 2003 to 2008, Director at Medical Present Value, Inc., Director at Vanda Pharmaceuticals, Inc., Director at Gloucester Pharmaceuticals, Inc., Director at Slacker, Inc., Independent Director at NGM Biopharmaceuticals, Inc. from 2008 to 2022, Managing Director at HealthCare Ventures LLC from 1994 to 1999, Director at Broadlogic Network Technologies, Inc., Director at Memory Pharmaceuticals Corp., Director at Medpace Research, Inc., Director at Orqis Medical Corp., Independent Director at Anacor Pharmaceuticals LLC from 2002 to 2016, Director at National Venture Capital Association, Director at Verenium Corp.
from 1999 to 2009, Director at ChargePoint, Inc., and Principal at McKinsey & Co., Inc.Mr. Leschly's education includes an undergraduate degree from Harvard University and an MBA from Stanford Graduate School of Business.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
18-07-2023 478 126 ( 0.11% ) 908 439 $ 31-03-2024
31-12-2022 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Mark Leschly

BedrijvenFunctieBegin
CHARGEPOINT HOLDINGS, INC. Director/Board Member 01-12-2009
Private Equity Investor 01-01-1999
Founder 01-01-2017
Director/Board Member 26-10-2010
Director/Board Member -
Chief Executive Officer -
Private Equity Investor -
Director/Board Member -
Director/Board Member -
Alle actieve functies van Mark Leschly

Eerdere bekende functies van Mark Leschly

BedrijvenFunctieEinde
░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Ervaring van Mark Leschly in detail bekijken

Opleiding van Mark Leschly

Harvard University Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Leschly in detail bekijken

Connecties

100 +

Eerstegraads connecties

35

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
NETMED, INC.

Health Technology

VANDA PHARMACEUTICALS INC.

Health Technology

NGM BIOPHARMACEUTICALS, INC.

Health Technology

CHARGEPOINT HOLDINGS, INC.

Retail Trade

Bedrijven in privébezit29

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Technology Services

Health Technology

Technology Services

Technology Services

Technology Services

Finance

Commercial Services

Electronic Technology

Finance

Health Technology

Distribution Services

Health Services

Finance

Health Technology

Commercial Services

Health Technology

Producer Manufacturing

Technology Services

Iconia LLC

Commercial Services

Technology Services

Finance

Finance

Distribution Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Leschly